Sermorelin
FDA-Approved GHRH (1-29) Fragment
Sermorelin is the synthetic GHRH(1-29) fragment, the minimum amino-acid sequence required for full biological activity of native growth hormone-releasing hormone. Originally FDA-approved as Geref, it remains a benchmark reference compound in somatotropic axis research and a frequent subject of preclinical longevity and aging studies. For laboratory research use only.
Acts as a GHRH receptor agonist on anterior pituitary somatotrophs, elevating intracellular cAMP and stimulating endogenous, pulsatile growth hormone release.
For Research Use Only. Sold for in vitro laboratory research. Not for human or veterinary consumption. By purchasing, you confirm you are 21+ and a qualified research professional.
Synthetic GHRH(1-29); the minimal sequence for biological activity.
Every batch of Sermorelin ships with an independently conducted Certificate of Analysis by Janoshik Analytical or Bioviridian. The COA includes HPLC-MS chromatogram, mass spec confirmation, endotoxin levels, and heavy metals screening.
Batch number is printed on the vial label and included in your order confirmation email. Look it up at pepidyn.com/coa.
